We are four partners with over fifty years practical experience in Life Science innovation management. Access to a highly competent scientific, technical and financial network of experts makes DRIMARCH special. We want to support you to accelerate your Research and Development projects in the Pharma, Animal Health and Agribusiness industry. 

René Amstutz, partner DRIMARCH

René Amstutz, PhD, partner

Extended experience in managing drug discovery departments and processes. Application and development of state-of-the-art discovery technologies: structural biology, analytics, lead finding activity, MRI, kilo-laboratory, antibody generation, protein production with a leading Pharma Research enterprise. Proven track record in developing drugs to the market. Experience in leading biotech company and advising start-up -  and venture companies.

Ruedi Gygax

Ruedi Gygax, PhD, partner

Experience in investment activities in biotech and start-up companies in venture capital set-ups (1996 – present). Board member of such companies during their foundation, through M&A transactions, turn-around situations, etc. Further activities in the areas of R&D management in Material Research (1990 - 1996) and Process Safety (1978 – 1989). Diploma in Chemistry and PhD in Physical Chemistry from the University of Basel, Switzerland and Post-Doctoral student at Stanford University.

Stefan Blarer, partner DRIMARCH

Stefan Blarer, PhD, managing director and partner

Accredited EU EASME and EU BlueInvest business coach, FFG Austria expert. Experienced in Management of Life Science R&D departments, R&D technology, Life Science business development. Member of Pharma and Agro Global R&D leadership teams, Novartis Corporate Research Advisory Board RAB, board of directors.

Christof Hildenbrand, partner DRIMARCH

 Christof Hildenbrand, PhD, partner 

Background: Global head of R&D with a leading Life Science company. Management of chemistry, biology, formulation, analytics, registration, toxicology and portfolio management activities. Full responsibilities for global R&D projects and budgets. Member of the board of director. proven track record in medicinal chemistry focused on parasitology and vaccines.